A small foreign particle can create a major pharmaceutical quality problem.

For manufacturers, discovering particulate matter in an injectable, vial, ampoule or other pharmaceutical product can trigger an investigation involving quality assurance, production, engineering, laboratories and regulatory teams. If the source cannot be identified and adequately controlled, the issue may escalate from a batch investigation to market action or recall.

This is why particle characterization reduces product recalls not simply by detecting particles, but by helping pharmaceutical manufacturers understand what the particle is, where it may have originated, and how it entered the product.

For pharmaceutical companies operating in Saudi Arabia, this approach is particularly relevant. The Saudi Food and Drug Authority (SFDA) maintains a formal recall framework for pharmaceutical products where quality, safety or efficacy deficiencies require corrective action.

Particle characterization therefore belongs within a broader contamination-control and investigation strategy.

The goal is straightforward: identify problems earlier, investigate them scientifically, establish credible root causes and prevent recurrence.

---

Why Pharmaceutical Particle Contamination Can Lead to Recalls

Particulate contamination is not merely an appearance issue.

For injectable products, unexpected particles can raise concerns about product quality and patient safety. USP <790> describes visible particulate matter in injections as extraneous mobile undissolved particles unintentionally present in solutions and includes examples such as fibers, glass, metal and elastomeric materials.

The FDA similarly emphasizes that visible particulates in injectable products can jeopardize patient safety and recommends a holistic, risk-based approach incorporating manufacturing controls, visual inspection, particulate identification, investigation and corrective actions.

A particle event can therefore lead to a chain of activities:

Particle detection → Batch investigation → Particle identification → Source investigation → Root cause assessment → CAPA → Batch disposition → Potential market action

The earlier the manufacturer can generate reliable analytical evidence, the more efficiently this chain can be managed.

---

What Is Particle Characterization?

Particle characterization is the systematic analysis of an unknown particle to determine its physical and/or chemical characteristics.

Depending on the sample, characterization may examine:

• Particle morphology
• Size and shape
• Surface characteristics
• Elemental composition
• Molecular structure
• Thermal behavior
• Material identity
• Potential relationship to manufacturing components

Common analytical technologies include:

• Microscopic analysis
• SEM with EDS
• FTIR
• TGA/STA

No single technology is automatically the best choice for every particle.

For example, SEM-EDS can provide high-resolution morphology and elemental information, while FTIR can provide molecular information for suitable organic, polymeric or elastomeric materials.

This complementary approach is one reason particle characterization reduces product recalls: it transforms an unknown observation into scientifically useful information.

---

How Particle Characterization Reduces Product Recalls

1. It Helps Identify Unknown Particles

The first advantage is obvious but important: characterization helps determine what an unknown particle actually is.

Imagine an injectable vial containing a small dark fragment.

Visual inspection may tell the analyst:

“There is a dark particle.”

But that does not answer:

• Is it metal?
• Is it polymer?
• Is it elastomer?
• Is it glass?
• Is it fiber?
• Is it environmental contamination?
• Is it a product-related precipitate?

Analytical characterization can narrow these possibilities.

That information becomes the foundation for the rest of the investigation.

---

2. It Helps Trace Potential Contamination Sources

Identification alone is not enough.

Suppose an unknown particle is characterized as a polymeric material.

The manufacturing facility may use polymers in:

• Tubing
• Filters
• Gaskets
• Seals
• Single-use assemblies
• Packaging components
• Other product-contact equipment

The next question becomes:

Which of these materials could realistically have generated the particle?

A structured particle investigation compares the unknown material with potential sources.

This is where a reference-material library becomes particularly valuable.

---

3. It Supports a Pharmaceutical Particle Reference Library

One proactive strategy is to characterize important materials before a contamination event occurs.

A manufacturer can identify relevant product-contact and non-product-contact materials and create analytical reference data.

A library could include:

• Stainless steel
• Elastomers
• Polymers
• Tubing
• Filters
• Gaskets
• Seals
• Glass
• Packaging materials
• Other process components

The analytical profiles can then be retained for future comparison.

Why is this useful?

Without a library, investigators may need to collect and characterize potential sources after an incident.

With a library, the investigation can potentially move faster from:

Unknown particle → Analytical profile → Candidate source → Manufacturing investigation

This can reduce uncertainty and improve the speed of decision-making.

---

4. It Strengthens Root Cause Investigations

A recall-prevention strategy cannot stop at “particle detected.”

The investigation needs to ask:

Why was the particle present?

This requires connecting laboratory findings with manufacturing information.

For example, an investigation may identify a particle as consistent with an elastomeric material.

The quality team can then review:

• Which elastomeric components were used?
• Which components contacted the product?
• Was a component replaced?
• Was maintenance performed?
• Was unusual wear observed?
• Were there deviations?
• Were there process interventions?
• Was the relevant component exposed to unusual conditions?

The analytical result does not automatically prove root cause, but it provides evidence that can guide the investigation.

---

5. It Helps Detect Equipment-Related Contamination

Manufacturing equipment can be a potential source of foreign particles.

Possible mechanisms include:

• Mechanical wear
• Component degradation
• Surface damage
• Corrosion
• Friction
• Seal deterioration
• Maintenance-related contamination

SEM-EDS can be particularly useful when elemental information is important.

For example, an unknown particle suspected of being metallic can be evaluated for morphology and elemental composition.

The result can then be compared with equipment materials.

If the analytical evidence is consistent with a particular component, engineers and QA teams have a much more focused starting point for their investigation.

---

6. It Helps Investigate Glass, Metal, Polymer and Fiber Contamination

Not all particles behave or appear the same way.

Potential foreign materials can include:

Glass

Potential sources include:

• Vials
• Ampoules
• Glass components
• Container handling operations

Metal

Potential sources include:

• Equipment
• Stainless-steel components
• Mechanical wear
• Maintenance activities

Polymer

Potential sources include:

• Tubing
• Single-use systems
• Plastic components
• Packaging materials

Elastomer

Potential sources include:

• Seals
• Stoppers
• Gaskets
• O-rings

Fibers

Potential sources can include:

• Personnel-related contamination
• Cleaning materials
• Packaging
• Process materials
• Environmental sources

The correct analytical approach depends on the particle.

---

SEM-EDS and FTIR: Complementary Tools for Particle Investigation

Two technologies frequently considered during particle characterization are SEM-EDS and FTIR.

SEM-EDS

Scanning Electron Microscopy can provide detailed information about particle morphology.

Energy Dispersive X-ray Spectroscopy can provide elemental information.

This makes SEM-EDS particularly useful when investigating:

• Metals
• Inorganic particles
• Glass-like materials
• Equipment-related particles
• Particles where elemental composition helps distinguish sources

FTIR

Fourier Transform Infrared Spectroscopy provides molecular information for materials that are suitable for infrared analysis.

It can be particularly useful for:

• Polymers
• Elastomers
• Organic materials
• Fibers
• Certain residues

Why use complementary methods?

A complex particle may require more than one type of evidence.

For example:

Microscopy → Morphology

SEM-EDS → Elemental information

FTIR → Molecular information

Reference comparison → Potential source

This combination can create a much stronger scientific basis for an investigation.

---

The Role of Particle Characterization in Injectable Product Quality

Injectable products deserve particular attention because they are administered directly into the body.

USP <1790> explains that visual inspection is a probabilistic process and that detection capability can vary depending on particle size, shape, color, density, dosage form and container design.

That means visual inspection remains essential, but it should not be treated as the complete contamination-investigation strategy.

A useful quality model is:

Prevention + Detection + Characterization + Investigation + CAPA

Particle characterization strengthens the middle of this system.

It helps answer questions that visual inspection alone cannot reliably answer.

---

Particle Characterization and Recall Prevention in Saudi Arabia

For pharmaceutical manufacturers serving the Saudi Arabian market, contamination investigations should be aligned with the company’s quality system and applicable SFDA requirements.

The SFDA’s Products Recall Guideline states that products may be subject to recall when they are suspected of being potentially harmful because of defective quality, safety or efficacy, and establishes responsibilities for recall operations.

The SFDA also maintains a searchable database of drug circulars and withdrawals so that information about products withdrawn from the Saudi market is publicly accessible.

This makes prevention and investigation especially important.

A manufacturer that can identify and investigate particulate issues early may be better positioned to:

• Contain affected batches
• Assess product impact
• Identify potential sources
• Implement corrective actions
• Evaluate recurrence risk
• Support scientifically justified batch decisions
• Reduce the likelihood of broader market impact

Particle characterization does not guarantee that a recall will never occur. Rather, it provides stronger evidence for quality decisions and contamination-control programs.

---

Recent Recall Events Show Why Particulate Investigation Matters

Particulate contamination remains a real-world pharmaceutical quality issue.

For example, recent FDA recall notices have included injectable products associated with particulate matter identified as iron oxide, fiberglass, stainless steel and glass.

One recent recall involving a Sun Pharma product concerned a lot of 675 vials of injectable product because of potential glass particles.

These examples demonstrate an important point:

Particle contamination can originate from very different materials and manufacturing pathways.

That is why simply describing a particle as “foreign matter” is often insufficient for a meaningful root cause investigation.

---

How to Build a Proactive Particle Investigation Program

Pharmaceutical manufacturers can take several practical steps.

Step 1: Identify High-Risk Materials

Create an inventory of materials that could potentially contribute particles.

Consider:

• Product-contact components
• Non-product-contact components
• Equipment
• Packaging
• Filters
• Tubing
• Seals
• Gaskets

---

Step 2: Develop a Reference Library

Where appropriate, characterize representative materials using suitable analytical techniques.

Maintain the resulting information in a controlled system.

---

Step 3: Define Particle Recovery Procedures

Your SOP should explain:

1. How the particle is detected.
2. How it is recovered.
3. How it is stored.
4. How sample identity is maintained.
5. How the sample is transferred for analysis.

Poor recovery can compromise an otherwise strong investigation.

---

Step 4: Establish an Analytical Decision Tree

Not every particle requires exactly the same analysis.

A decision framework might consider:

Visual/microscopic examination

↓

Is elemental information important?

→ Consider SEM-EDS.

Is molecular/material information important?

→ Consider FTIR.

Is additional thermal/material behavior information needed?

→ Consider TGA/STA.

This approach avoids treating every investigation identically.

---

Five Common Mistakes That Can Increase Recall Risk

1. Treating Visual Inspection as the Final Answer

Visual inspection can detect particles, but it generally does not establish their material identity.

2. Investigating Only After a Major Event

A proactive particle library can reduce investigation time when an unknown particle appears.

3. Assuming the Source Without Evidence

Finding a material that “looks similar” is not sufficient to establish the source.

4. Ignoring Manufacturing History

Analytical evidence must be combined with equipment, process, maintenance and batch information.

5. Failing to Convert Findings Into CAPA

A particle investigation should ultimately contribute to contamination prevention and recurrence reduction where a preventable cause is established.

---

A Practical Example for a Saudi Pharmaceutical Manufacturer

Consider a hypothetical manufacturer producing sterile injectable vials in Saudi Arabia.

During inspection, an analyst identifies a small unknown particle.

Stage 1: Detection

The vial is segregated according to the company’s established procedure.

Stage 2: Documentation

The particle’s appearance, location and other relevant observations are recorded.

Stage 3: Recovery

The particle is carefully recovered and preserved for analysis.

Stage 4: Characterization

Microscopy is performed, followed by suitable instrumental analysis.

Suppose SEM-EDS indicates an inorganic/elemental profile.

Stage 5: Source Assessment

The manufacturing team reviews:

• Filling equipment
• Product-contact components
• Maintenance records
• Equipment condition
• Recent component changes

Stage 6: Reference Comparison

Potential source materials are compared with the unknown particle.

Stage 7: Root Cause Investigation

The analytical evidence is evaluated alongside manufacturing evidence.

Stage 8: CAPA

If a credible source is established, corrective and preventive measures are implemented.

The advantage is clear: the investigation moves from “we found a particle” to “we have evidence about what it is and where to investigate.”

That is how particle characterization reduces product recalls as part of a broader quality strategy.

---

7 Ways Particle Characterization Can Strengthen Recall Prevention

1. Faster identification

Knowing the material can narrow the investigation.

2. Better source tracing

Reference materials can be compared against unknown particles.

3. Stronger root cause evidence

Analytical data can support manufacturing investigations.

4. Better CAPA decisions

Corrective action can be directed toward a credible source.

5. Improved contamination control

Recurring contamination patterns can be recognized.

6. Better risk assessment

Quality teams can make more informed decisions about affected batches.

7. Reduced uncertainty

Scientific characterization provides evidence beyond visual appearance.

---

FAQ: Particle Characterization and Product Recalls

Can particle characterization prevent every pharmaceutical recall?

No. Particle characterization is one component of a broader quality and contamination-control strategy. It can improve identification, investigation and source assessment, but it cannot eliminate every possible manufacturing failure.

Does particle characterization replace visual inspection?

No. Visual inspection remains an important control for injectable products. USP <790> and <1790> specifically address visible particulate inspection, while particle characterization provides additional analytical information when particles require investigation.

Which particles should be analyzed?

Unknown, unexpected or potentially significant particles may require characterization depending on the investigation, product, risk assessment and applicable procedures.

Is SEM-EDS enough to identify every particle?

No. SEM-EDS is powerful for morphology and elemental information, but it may not provide the molecular information required for some organic or polymeric materials. Complementary methods such as FTIR may therefore be appropriate.

Why create a particle reference library?

A reference library allows manufacturers to establish analytical profiles of relevant process materials before an investigation occurs. This can make future source comparisons more efficient.

Can particle characterization support CAPA?

Yes. Characterization can provide evidence that helps connect an unknown particle to potential manufacturing sources. The resulting evidence can contribute to root cause analysis and appropriate CAPA.

Is particle characterization useful for Saudi pharmaceutical manufacturers?

Yes. Manufacturers operating in Saudi Arabia can incorporate particle characterization into their contamination investigation and pharmaceutical quality strategies while ensuring that their procedures remain aligned with applicable SFDA requirements and their own quality systems.

---

Conclusion: Turn Unknown Particles Into Actionable Quality Information

A pharmaceutical recall can have significant consequences for patients, manufacturers, supply chains and regulatory relationships.

The best strategy is not simply to react after contamination becomes a major problem.

It is to build a system that can detect, identify, investigate and prevent particulate contamination as effectively as possible.

That is where particle characterization reduces product recalls.

By combining microscopic analysis, SEM-EDS, FTIR, TGA/STA and reference-material comparison where appropriate, pharmaceutical manufacturers can gain a much clearer understanding of unknown particles.

More importantly, particle characterization can connect laboratory evidence with manufacturing information.

The result is a stronger investigation:

Detect the particle → Recover it correctly → Characterize it → Compare potential sources → Investigate the process → Establish root cause → Implement CAPA

For pharmaceutical manufacturers in Saudi Arabia, this approach can strengthen contamination-control programs and provide valuable analytical evidence during quality investigations.

If your organization needs support with unknown particle identification, pharmaceutical contamination analysis, reference-library development or advanced particle characterization, specialized analytical services can provide the technologies and expertise required for complex investigations.

Take the Next Step

Explore Particle Characterization Analysis Services to learn how advanced particle characterization can support pharmaceutical contamination investigations and quality-control activities.

Your trusted partner for pharma skills, systems, and solutions.